Similar Articles
401 Recent advances in recurrent hepatocellular carcinoma therapy
402 Ablative strategies for recurrent hepatocellular carcinoma
403 Inferior outcomes of liver transplantation for hepatocellular carcinoma during early-COVID-19 pandemic in the United States
404 Lipid metabolism of hepatocellular carcinoma impacts targeted therapy and immunotherapy
405 Comprehensive analysis of prognostic value and immunotherapy prospect of brain cytoplasmic RNA1 in hepatocellular carcinoma
406 Role of adjuvant chemotherapy on recurrence and survival in patients with resected ampulla of Vater carcinoma
407 Correlation between immune-related adverse events and long-term outcomes in pembrolizumab-treated patients with unresectable hepatocellular carcinoma: A retrospective study
408 Liver transplantation in the management of cholangiocarcinoma: Evolution and contemporary advances
409 Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics
410 Hepatocellular carcinoma: State of the art diagnostic imaging
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA